View By Speaker
M. Agronin, MD
M. Alexander, PhD, MA
S. Ancoli-Israel, Ph.D
L. Boesky, PhD
R. Brown, PhD
A. Burstein, MD
R. Dougherty, PhD
J. Draud, MD, MS
P. Earley
G. Emslie, MD
L. Ereshefsky, PharmD
M. Forstein, MD
A. Frances, MD
M. Gold, MD
D. Goodman, MD
K. Gray, MD
D. Greenberg, MD
D. Greydanus, MD
R. Hendren, DO
R. Jackson, MD
R. Jain, MD, MPH
S. Jain, PsyD, LPC, MBA
J. Kane, MD
S. Katz, MSN PMH-CNS, BC
L. Kinsella, MD, FAAN
A. Krystal, MD
S. Levine, MD
J. Maldonado, MD
V. Maletic, MD, PA
B. McCarberg, MD
J. McGough, MD, MS
L. Miller, MD
L. Nagy, MD
H. Nasrallah, MD
S. Negi, MA, PhD
J. Nelson, MD
J. Newcomer, MD
G. Papakostas, MD
M. Piasecki, MD
J. Prince, MD
C. Raison, MD
P. Resnick, MD
A. Robb, MD
C. Rodgers, MD
M. Rosenberg, MD, PhD
J. Schim, MD
D. Schuyler, MD
S. Shea, MD
T. Simpatico, MD
T. Skale, MD
B. Smith, JD
T. Smith, MS Psych, PD, FASCP, LMHC, NCP
S. Sobel, MD
D. Sprague
M. Stein, MD, MPH
R. Stille, MBA
V. Strasburger, MD
J. Tsuang, MD
S. Verma, MD
J. Victoroff, MD, MA
J. Weiner, MD, PhD
S. Yaffe, MD
A. Young, MD, MSHS
|
I Industry-Supported Symposia| Monday, November 2 09:15- 10:30 a.m. |
120 - Diagnosis and Treatment of ADHD in Children and Adults: A Fresh Appraisal I PD RX
1.25 credits - Room: Mandalay Bay Ballroom KL |
Adelaide S. Robb, MD, Associate Professor, Psychiatry and Pediatrics; George Washington University School of Medicine; Associate Professor, Child and Adolescent Psychiatry; Children's National Medical Center; Washington, DC
David W. Goodman, MD, Assistant Professor, Psychiatry and Behavioral Sciences; The Johns Hopkins University School of Medicine; Baltimore, Maryland; Director, Adult Attention Deficit Disorder Center of Maryland; Lutherville, Maryland
|
The session will provide participants with recent clinical trial data on therapeutics for the treatment of ADHD. In addition the symposium will focus on recognizing, reducing, and addressing stimulant abuse and diversion. This activity is supported by an educational grant from Eli Lilly and Company. This activity is sponsored by CME LLC. Veritas Institute for Medical Education, Inc. is the content provider. |
| Monday, November 2 10:45-12:00 p.m. |
140 - Treating Adolescent Depression: An Evidence-Based Update on Efficacy and Safety I PD RX
1.25 credits - Room: Mandalay Bay Ballroom KL |
Ronald T. Brown, PhD, DeanProfessor of Public HealthTemple University Health Sciences CenterCollege of Health Professions Philadelphia, PA
Graham J. Emslie, MD, UT Southwestern Medical Center Children's Medical Center Dallas, TX
|
The session will provide participants with strategies for the management of adolescents with depression. This activity is supported by an educational grant from Forest Laboratories, Inc. This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. The Institute for Continuing Healthcare Education is the content provider. |
| Monday, November 2 12:15-2:15 p.m. |
160 - Spotlight on Schizophrenia: Challenges in Diagnosis and Treatment I PD RX
1.5 credits - Room: Mandalay Bay Ballroom EFGH |
Alexander S. Young, MD, MSHS, Professor, UCLA Department of Psychiatry; Director, Health Services; VA Desert Pacific Mental Illness Research Education and Clinical Center (MIRECC); Los Angeles, CA
John M. Kane, MD, Chairman, Department of Psychiatry; The Zucker Hillside Hospital; Professor of Psychiatry, Neurology and Neuroscience; The Albert Einstein College of Medicine
|
The session will provide participants with practical strategies for the diagnosis, treatment, and long term management of patients with schizophrenia. 12:15 - 12:45 p.m. Lunch
12:45- 2:15 p.m. Symposium This activity is supported by an educational grant from Eli Lilly and Company.
This activity is sponsored by CME LLC. CME Outfitters is the content provider. |
| Tuesday, November 3 07:00-09:00 a.m. |
210 - Insomnia: A Healthcare Gap that is Growing PD RX I
1.5 credits - Room: Mandalay Bay Ballroom GH |
Sonia Ancoli-Israel, Ph.D, Professor of Psychiatry; Director, Gillin Sleep and Chronomedicine Research Center; University of Californialifornia, San Diego; La Jolla, CA
Andrew D. Krystal, MD, Associate Professor; Department of Psychiatry; Duke University Medical Center; Durham, North Carolina
|
The session will provide participants with insight into insomnia management through discussions of assessment, treatment implications, and patient education strategies. 7:00-7:30 a.m. Breakfast
7:30-9:00 a.m. Symposium This activity is supported by an educational grant from sanofi-aventis U.S. This activity is sponsored by CME LLC. MediCom Worldwide, Inc. is the content provider. |
| Tuesday, November 3 10:45-12:00 p.m. |
250 - Continuity of Care: Practical Tools for the Management of Patients with Schizophrenia PD RX I
1.25 credits - Room: Mandalay Bay Ballroom AB |
Henry A. Nasrallah, MD, Professor of Psychiatry and Neuroscience; Director, Schizophrenia Research Programs; Department of Psychiatry; College of Medicine
John W. Newcomer, MD, Gregory B. Couch Professor of Psychiatry, Psychology & Medicine; Director, Clinical Trials Unit, Institute of Cinical and Translational Sciences; Director, Regulatory Support Center, ICTS Medical Director, Center for Clincal Studies; Washington University
|
The session will provide participants with practical tools for the continuity of care for patients with schizophrenia. This activity is supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. administered by Ortho-McNeil Janssen Scientific Affairs, LLC This activity is jointly sponsored by the Indiana University School of Medicine and CME LLC. CME Outfitters is the content provider. |
| Tuesday, November 3 12:15-2:15 p.m. |
260 - ADHD in Adolescents and Adults: Recognizing the Signs, Optimizing Care I PD RX
1.5 credits - Room: Mandalay Bay Ballroom EF |
Donald E. Greydanus, MD, Pediatrics Program Director; MSU/Kalamazoo Center for Medical Studies; Kalamazoo, MI
James J. McGough, MD, MS, Professor, Clinical Psychiatry; UCLA Semel Institute for Neuroscience and Human Behavior; Los Angeles, CA
|
The session will provide participants strategies and reinforcement in dose titration, multimodal treatment, and long-term treatment adherence for patients with ADHD. 12:15 - 12:45 p.m. Lunch
12:45- 2:15 p.m. Symposium This activity is supported by an educational grant from McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. Veritas Institute for Medical Education Inc. is the content provider. |
| Tuesday, November 3 12:15-2:15 p.m. |
270 - Depression and Pain: Advances in Neurobiology and Treatment I PD RX
1.5 credits - Room: Mandalay Bay Ballroom GH |
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
|
The session will provide participants with strategies for improving the management of comorbid depression as well as chronic pain and other physical symptoms. 12:15PM-12:45 p.m. Lunch
12:45-2:15 p.m. Symposium This activity is supported by an educational grant from Eli Lilly and Company. This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. The Institute for Continuing Healthcare Education is the content provider. |
| Wednesday, November 4 07:00-09:00 a.m. |
310 - Addressing ADHD Issues Across the Life Span: Optimizing Patient Management Strategies I PD RX
1.5 credits - Room: Mandalay Bay Ballroom GH |
Doris Greenberg, MD, Associate Clinical Professor, Pediatrics; Mercer University School of Medicine; Developmental and Behavioral Pediatrician; Backus Children's Hospital at Memorial University Medical Center; Savannah, Georgia
Jefferson B. Prince, MD, Director, Child Psychiatry; North Shore Medical Center; Salem, Massachusetts; Staff, Child Psychiatry; Massachusetts General Hospital/Harvard Medical School; Boston, Massachusetts
|
The session will provide participants with education on the proper screening, diagnosis, and treatment of ADHD in children, adolescents, and adults. 7:00-7:30 a.m. Breakfast
7:30-9:00 a.m. Symposium This educational activity is supported by an independent medical educational grant from Shire.
This activity is sponsored by CME LLC. Veritas Institute for Medical Education, Inc. is the content provider. |
| Wednesday, November 4 01:00 - 02:15 p.m. |
320 - Impact of Nonadherence on the Comorbid Patient: Overcoming Clinical Challenges in Psychiatric Care I
1.25 credits - Room: Mandalay Bay Ballroom IJ |
Saundra Jain, PsyD, LPC, MBA, Executive Director, Mental Health Educational Initiative, Lake Jackson, Texas
Charles Raison, MD, Associate Professor
Clinical Director Mind-Body Program
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
|
The session will encourage participants to explore the barriers of recognition and management of nonadherence in psychiatric patients with comorbid conditions and provide skills to balance long-term treatment requirements with optimized chronic care delivery. This activty is supported by an educational grant from Eli Lilly and Company and Bristol-Myers Squibb and Otsuka America Pharmaceuticals, Inc. This activity is sponsored by CME LLC. |
| Wednesday, November 4 02:30-03:45 p.m. |
330 - Role of Atypical Antipsychotics in Major Depressive Disorder: Consideration of Patient Functionality and Wellness PD RX I
1.25 credits - Room: Mandalay Bay Ballroom CD |
J. Craig Nelson, MD, Leon J Epstein Professor of Psychiatry; Director, Geriatric Psychiatry; University of San Francisco
George I. Papakostas, MD, Associate Professor of Psychiatry; Massachusetts General Hospital; Boston, MA
|
The session will provide participants with strategies for improving rates of remission for major depressive disorder (MDD), including treatment resistant depression, along with combination and augmentation strategies for depression with atypical antipsychotics. This activity is supported by an educational grant from Bristol-Myers Squibb and Otsuka America Pharmaceutical, Inc. This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. The Institute for Continuing Healthcare Education is the content provider. |
|
